# Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery

> **NCT03289325** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 285 (actual)

## Conditions studied

- Cardiac Surgery
- Dexmedetomidine
- Long-term Outcome
- Mortality
- Quality of Life

## Interventions

- **DRUG:** dexmedetomidine hydrochloride for injection
- **DRUG:** 0.9% sodium chloride for injection

## Key facts

- **NCT ID:** NCT03289325
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-21
- **Primary completion:** 2022-05-03
- **Final completion:** 2022-05-03
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03289325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03289325, "Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03289325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*